Detalles de la búsqueda
1.
Dorsal root ganglion stimulator-A targeted therapy for post-herpetic neuralgia: The Middle East Experience.
Pain Pract
; 24(3): 567-572, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38050874
2.
Chemotherapy (doublet or triplet) plus targeted therapy by RAS status as conversion therapy in colorectal cancer patients with initially unresectable liver-only metastases. The UNICANCER PRODIGE-14 randomised clinical trial.
Br J Cancer
; 126(9): 1264-1270, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34992255
3.
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial.
Lancet Oncol
; 22(5): 702-715, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33862000
4.
Role of FOLFIRINOX and chemoradiotherapy in locally advanced and borderline resectable pancreatic adenocarcinoma: update of the AGEO cohort.
Br J Cancer
; 124(12): 1941-1948, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33772154
5.
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
N Engl J Med
; 379(25): 2395-2406, 2018 12 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30575490
6.
Effectiveness of first-line cetuximab in wild-type RAS metastatic colorectal cancer according to tumour BRAF mutation status from the EREBUS cohort.
Br J Clin Pharmacol
; 87(3): 1120-1128, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32656857
7.
Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab.
Gut
; 69(3): 531-539, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31101691
8.
Predictive factors for early progression during induction chemotherapy and chemotherapy-free interval: analysis from PRODIGE 9 trial.
Br J Cancer
; 122(7): 957-962, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32015513
9.
DPD status and fluoropyrimidines-based treatment: high activity matters too.
BMC Cancer
; 20(1): 436, 2020 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32423482
10.
Atezolizumab plus modified docetaxel-cisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: a randomized, non-comparative phase II SCARCE GERCOR trial.
BMC Cancer
; 20(1): 352, 2020 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-32334548
11.
Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the Lauren classification and its prognostic significance.
Gastric Cancer
; 23(1): 73-81, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31267360
12.
Anti-Telomerase CD4+ Th1 Immunity and Monocytic-Myeloid-Derived-Suppressor Cells Are Associated with Long-Term Efficacy Achieved by Docetaxel, Cisplatin, and 5-Fluorouracil (DCF) in Advanced Anal Squamous Cell Carcinoma: Translational Study of Epitopes-HPV01 and 02 Trials.
Int J Mol Sci
; 21(18)2020 Sep 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-32957741
13.
Characteristics of BRAFV600E Mutant, Deficient Mismatch Repair/Proficient Mismatch Repair, Metastatic Colorectal Cancer: A Multicenter Series of 287 Patients.
Oncologist
; 24(12): e1331-e1340, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31152084
14.
Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study.
Lancet Oncol
; 19(8): 1094-1106, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30042063
15.
Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study).
BMC Cancer
; 17(1): 574, 2017 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-28841909
16.
Multimodal Therapy of Squamous Cell Carcinoma of the Anus With Distant Metastasis: A Single-Institution Experience.
Dis Colon Rectum
; 60(8): 785-791, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28682963
17.
Population Pharmacokinetics of Gemcitabine and dFdU in Pancreatic Cancer Patients Using an Optimal Design, Sparse Sampling Approach.
Ther Drug Monit
; 39(3): 290-296, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28346313
18.
Effectiveness and Tolerability of Maintenance Capecitabine Administrated to Patients with Metastatic Pancreatic Cancer Treated with First-Line FOLFIRINOX.
Oncology
; 90(5): 261-6, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27097162
19.
First-Line Chemotherapy for Metastatic Esophageal Squamous Cell Carcinoma: Clinico-Biological Predictors of Disease Control.
Oncology
; 90(2): 88-96, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26784946
20.
Dorsal Root Ganglion (DRG) Stimulation in the Treatment of Phantom Limb Pain (PLP).
Neuromodulation
; 18(7): 610-6; discussion 616-7, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26268453